Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial
Clinical trial NCT05607329 · RECRUITING
Trial details
- NCT number
- NCT05607329
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.